Publications by authors named "Hannah Fuchs"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

1,878

Total Likes

370

Extended Reach

1,033,079

Social Features

226
P
Provider billing margin and cancer treatment selection: population based cohort study.
Aaron P Mitchell, Stacie B Dusetzina, Akriti Mishra Meza, Grace Gallagher, Patrick Augello, Hannah Fuchs

BMJ· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic interference with SARS-CoV-2 replication by molnupiravir-derived N-hydroxycytidine and inhibitors of CTP synthetase in cell culture.
Kim M Stegmann, Antje Dickmanns, Hannah L Fuchs, David Scheibner, Björn-Patrick Mohl

Virology· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher Risk Renal Angiomyolipomas: Surveillance Remains a Safe Management Option.
Mark T Dawidek, Juan Sebastian Arroyave Villada, Katiana Vazquez-Rivera, Hannah Fuchs, Lina Posada Calderon

Urol Pract· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Treatment Selection for Medicare Beneficiaries With Cancer.
Aaron P Mitchell, Sonia Persaud, Akriti Mishra Meza, Hannah E Fuchs, Prabal De

J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitors of dihydroorotate dehydrogenase synergize with the broad antiviral activity of 4'-fluorouridine.
Leon Schrell, Hannah L Fuchs, Antje Dickmanns, David Scheibner, Judith Olejnik

Antiviral Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Selective Operative Drainage After Pancreatic Resection: A Retrospective Analysis of 2,607 Patients.
Josephine Magnin, Joshua S Jolissaint, Hannah E Fuchs, Kenneth Seier, Mithat Gonen

Ann Surg· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation Strategies to Promote Short-Course Radiation for Bone Metastases.
Erin F Gillespie, Patricia Mae G Santos, Michael Curry, Talya Salz, Nirjhar Chakraborty, Hannah E Fuchs

JAMA Netw Open· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiorespiratory Fitness in Patients With Early-Stage Breast Cancer and Radiation Therapy-Related Fatigue: A Prospective Pilot Study.
Jonathan E Leeman, Kaitlyn Lapen, Hannah E Fuchs, Mithat Goner, Meghan Michalski

Int J Radiat Oncol Biol Phys· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker Inference and the Timing of Next-Generation Sequencing in a Multi-Institutional, Cross-Cancer Clinicogenomic Data Set.
Kenneth L Kehl, Jessica A Lavery, Samantha Brown, Hannah Fuchs, Gregory Riely

JCO Precis Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Characterization and Clinical Outcomes of Patients with Peritoneal Metastases from the AACR GENIE Biopharma Collaborative Colorectal Cancer Registry.
Enrique Sanz-Garcia, Samantha Brown, Jessica A Lavery, Jessica Weiss, Hannah E Fuchs

Cancer Res Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing racial and ethnic disparities in AACR project GENIE.
Shawn M Sweeney, Jessica A Lavery, Hannah E Fuchs, Jocelyn A Lee, Samantha Brown

NPJ Precis Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor monocyte content predicts immunochemotherapy outcomes in esophageal adenocarcinoma.
Thomas M Carroll, Joseph A Chadwick, Richard P Owen, Michael J White, Joseph Kaplinsky, Hannah S Fuchs

Cancer Cell· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'Do both': glo events and promotion in Germany.
Kathleen Gali, Hannah Fuchs, Judith J Prochaska

Tob Control· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin B Supplementation and Vitamin B Blood Serum Levels: Evaluation of Effect Modification by Gender and Smoking Status.
Hannah E Fuchs, Kelli O'Connell, Mengmeng Du, Sandi L Navarro, Theodore M Brasky

Nutr Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer statistics, 2022.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal

CA Cancer J Clin· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
To Improve Pain and Function, Platelet-Rich Plasma Injections May Be an Alternative to Surgery for Treating Lateral Epicondylitis: A Systematic Review.
Richard Hardy, Aerika Tori, Hannah Fuchs, Taiyo Larson, Jefferson Brand

Arthroscopy· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer statistics for the US Hispanic/Latino population, 2021.
Kimberly D Miller, Ana P Ortiz, Paulo S Pinheiro, Priti Bandi, Adair Minihan, Hannah E Fuchs

CA Cancer J Clin· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain and other central nervous system tumor statistics, 2021.
Kimberly D Miller, Quinn T Ostrom, Carol Kruchko, Nirav Patil, Tarik Tihan, Hannah E Fuchs

CA Cancer J Clin· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between iHOT12 and HOS scores in hip pain patients.
Jeff Brand, Rich Hardy, Aerika Tori, Hannah Fuchs, Engin Sungur

J Hip Preserv Surg· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified biweekly cisplatin, docetaxel plus cetuximab (TPEx) as first-line treatment for patients with recurrent/metastatic head and neck cancer.
Hannah Fuchs, Johannes Pammer, Christoph Minichsdorfer, Doris Posch, Gabriela Kornek

Med Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel plus cetuximab biweekly is an active regimen for the first-line treatment of patients with recurrent/metastatic head and neck cancer.
Doris Posch, Hannah Fuchs, Gabriela Kornek, Anja Grah, Johannes Pammer

Sci Rep· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis